Cell filtration‐laser scanning cytometry for the characterisation of circulating breast cancer cells
Lila Zabaglo(Royal Marsden NHS Foundation Trust), Mitch Dowsett(Royal Marsden NHS Foundation Trust), Alistair Ring(Brighton and Sussex Medical School), Marina Parton(Royal Marsden Hospital), Ian E. Smith(Royal Bournemouth Hospital), M.G. Ormerod(Royal Marsden NHS Foundation Trust)
Cited by 99
Related Papers
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Mechanisms of tamoxifen resistance
|Endocrine Related Cancer|2004|652
Relationship Between Quantitative Estrogen and Progesterone Receptor Expression and Human Epidermal Growth Factor Receptor 2 (HER-2) Status With Recurrence in the Arimidex, Tamoxifen, Alone or in Combination Trial
|Journal of Clinical Oncology|2008|464
Assessment of Molecular Relapse Detection in Early-Stage Breast Cancer
|JAMA Oncology|2019|425